Several studies have reported CCR6+ SARS-CoV-2-specific T cells in convalescent COVID-19 patients (Biasi et al., 2020; Juno et al., 2020; Moderbacher et al., 2020), but their durability was unknown. Here, CCR6 is linked to COVID-19.